NWF Advisory Services Inc.

Position in BMY — Bristol Myers Squibb Co

CIK 2045735 Los Angeles, CA

Position in BMY

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$360,413

-$37,754 QoQ

Shares Held

6,255

-4.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#1,744

of 2,506 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

NWF Advisory Services Inc. holds $14,660,430 across 10 Drug Manufacturers - General names. BMY ranks #8 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	12,825	$3,227,283
2	LLY	ELI LILLY & Co	2,136	$2,561,982
3	JNJ	Johnson & Johnson	9,493	$2,410,937
4	AMGN	Amgen Inc	5,766	$2,087,983
5	MRK	Merck & Co., Inc.	14,785	$1,899,872
6	PFE	Pfizer Inc	38,937	$937,602
7	AZN	Astrazeneca PLC	3,332	$631,813
8	BMY	Bristol Myers Squibb Co This page	6,255	$360,413

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$360,413	6,255	-4.7%	Shares	Sole	2026-07-29
2026-03-31	$398,167	6,565	+2.5%	Shares	Sole	2026-05-04
2025-12-31	$345,431	6,404	+3.3%	Shares	Sole	2026-03-03
2025-09-30	$279,710	6,202	-6.6%	Shares	Sole	2025-10-31
2025-06-30	$307,411	6,641	+1.6%	Shares	Sole	2025-09-09
2025-03-31	$398,813	6,539	+3.0%	Shares	Sole	2025-08-12
2024-09-30	$328,445	6,348	+0.2%	Shares	Sole	2025-10-06
2024-06-30	$263,217	6,338	-8.0%	Shares	Sole	2025-10-06
2024-03-31	$373,753	6,892	+2.4%	Shares	Sole	2025-10-06
2023-12-31	$345,418	6,732	+21.5%	Shares	Sole	2025-12-08
2023-09-30	$321,657	5,542	+13.3%	Shares	Sole	2025-12-08
2023-06-30	$312,715	4,890	0.0%	Shares	Sole	2025-12-08
2023-03-31	$338,925	4,890	—	Shares	Sole	2025-12-08
No filing history on record for this holder in this stock.